366
Views
0
CrossRef citations to date
0
Altmetric
Research Article

L- Thyroxine ameliorates renal function in thyroidectomized diabetic nephropathy rats through downregulation of TGF- β1, Ang II and ET-1 expression

, , , &
Pages 632-649 | Received 03 Jun 2023, Accepted 12 Aug 2023, Published online: 01 Sep 2023

References

  • Roh E, Noh E, Hwang SY, et al. Increased risk of type 2 Diabetes in patients with thyroid cancer after thyroidectomy: a nationwide cohort study. J Clin Endocrinol Metab. 2022;107:E1047–56. doi: 10.1210/CLINEM/DGAB776
  • Lotfy M, Adeghate J, Kalasz H, et al. Chronic complications of Diabetes mellitus: a mini review. Curr Diabetes Rev. 2017;13:3–10. doi: 10.2174/1573399812666151016101622
  • Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diab Obes Metab. 2020;22(1):3–15. doi: 10.1111/DOM.14007
  • Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Methods Mol Biol. 2020;2067:3–7. doi: 10.1007/978-1-4939-9841-8_1
  • Joo EY, Kim YJ, Go Y, et al. Relationship between perioperative thyroid function and acute kidney injury after thyroidectomy. Sci Rep. 2018;8:13539. doi: 10.1038/S41598-018-31946-W
  • Talwalkar P, Deshmukh V, Bhole M. Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study. Diabetes Metab Syndr Obes. 2019;12:369–376. doi: 10.2147/DMSO.S181470
  • Zhao W, Li X, Liu X, et al. Thyroid function in patients with type 2 Diabetes mellitus and diabetic nephropathy: a single center study. J Thyroid Res. 2018;2018:1–7. doi: 10.1155/2018/9507028
  • Han Q, Zhang J, Wang Y, et al. Thyroid hormones and diabetic nephropathy: an essential relationship to recognize. Nephrology (Carlton). 2019;24:160–169. doi: 10.1111/NEP.13388
  • Seo C, Kim S, Lee M, et al. THYROID HORMONE REPLACEMENT REDUCES the RISK of CARDIOVASCULAR DISEASES in DIABETIC NEPHROPATHY PATIENTS with SUBCLINICAL HYPOTHYROIDISM. Endocr Pract. 2018;24:265–272. doi: 10.4158/EP-2017-0017
  • Chen Y, Wu G, Xu M. The effect of l-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study. Int Urol Nephrol. 2017;50:97–103. doi: 10.1007/S11255-017-1756-Y
  • Egido J, Rojas-Rivera J, Mas S, et al. Atrasentan for the treatment of diabetic nephropathy. Expert Opin Investig Drugs. 2017;26:741–750. doi: 10.1080/13543784.2017.1325872
  • Kim Y, Kleppel MM, Butkowski R, et al. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol. 1991;138:413.
  • Fernandez-Fernandez B, Ortiz A, Gomez-Guerrero C, et al. Therapeutic approaches to diabetic nephropathy–beyond the RAS. Nat Rev Nephrol. 2014;10:325–346. doi: 10.1038/NRNEPH.2014.74
  • Leehey DJ, Singh AK, Alavi N, et al. Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 2000;58:S93–8. doi: 10.1046/j.1523-1755.2000.07715.x
  • Su W, Cao R, He YC, et al. Crosstalk of hyperglycemia and dyslipidemia in diabetic kidney disease. Kidney Diseases. 2017;3:171. doi: 10.1159/000479874
  • Zhang F, Ren X, Zhao M, et al. Angiotensin-(1–7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways. Sci Rep. 2016;6:1–11. doi: 10.1038/srep34621
  • Zhao L, Zou Y, Liu F. Transforming growth factor-beta1 in diabetic kidney disease. Front Cell Dev Biol. 2020;8:187. doi: 10.3389/FCELL.2020.00187
  • Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415. doi: 10.1038/332411A0
  • Kohan DE, Rossi NF, Inscho EW, et al. Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev. 2011;91:1–77. doi: 10.1152/PHYSREV.00060.2009
  • Amiri F, Paradis P, Reudelhuber TL, et al. Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells. J Hypertens. 2008;26:1102–1109. doi: 10.1097/HJH.0B013E3282FC2184
  • Zhang L, Xue S, Hou J, et al. Endothelin receptor antagonists for the treatment of diabetic nephropathy: a meta-analysis and systematic review. World J Diabetes. 2020;11:553–566. doi: 10.4239/WJD.V11.I11.553
  • Charbonneau A, Unson CG, Lavoie JM. High-fat diet-induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exercise. J Physiol. 2007;579:255. doi: 10.1113/JPHYSIOL.2006.121954
  • Lee JJ, Yi HY, Yang JW, et al. Characterization of streptozotocin-induced diabetic rats and pharmacodynamics of insulin formulations. Biosci Biotechnol Biochem. 2003;67:2396–2401. doi: 10.1271/BBB.67.2396
  • Cimen S, AK CS, SM CT. Impact of Polyethylene Glycol and Dextran 70 treatment on Adhesion Formation after subtotal thyroidectomy. Int J Surg Res. 2013;2:8–12. doi: 10.5923/j.surgery.20130202.02
  • Jin J, Allemang MT, McHenry CR. Levothyroxine replacement dosage determination after thyroidectomy. Am J Surg. 2013;205:360–364. doi: 10.1016/J.AMJSURG.2012.10.015
  • Waynforth HB, Flecknell PA. Experimental and surgical technique in the rat. Scientific Library. 1992;382. QY 58 .W3591.
  • Brzóska MM, Moniuszko-Jakoniuk J, Piłat-Marcinkiewicz B, et al. Liver and kidney function and histology in rats exposed to cadmium and ethanol. Alcohol Alcohol. 2003;38:2–10. doi: 10.1093/ALCALC/AGG006
  • Roza NAV, Possignolo LF, Palanch AC, et al. Effect of long-term high-fat diet intake on peripheral insulin sensibility, blood pressure, and renal function in female rats. Food Nutr Res. 2016;60:60. doi: 10.3402/FNR.V60.28536
  • Ebrahim NA, Leach L. Transendothelial migration of human umbilical mesenchymal stem cells across uterine endothelial monolayers: junctional dynamics and putative mechanisms. Placenta. 2016;48:87–98. doi: 10.1016/J.PLACENTA.2016.10.014
  • Kengkoom K, Angkhasirisap W, Kanjanapruthipong T, et al. Streptozotocin induces alpha-2u globulin nephropathy in male rats during diabetic kidney disease. BMC Vet Res. 2021;17:1–9. doi: 10.1186/s12917-021-02814-z
  • Russo LM, Del Re E, Brown D, et al. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes. 2007;56:380–388. doi: 10.2337/DB06-1018
  • Wang L, Wang H, Lan H. TGF-β signaling in diabetic nephropathy: an update. Diabetic Nephropathy. 2022;2:7–16. doi: 10.2478/DINE-2022-0011
  • Meng XM, Huang XR, Chung ACK, et al. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol. 2010;21:1477–1487. doi: 10.1681/ASN.2009121244
  • Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75:1–9. doi: 10.1111/J.1365-2265.2011.04029.X
  • Teixeira SD, Panveloski‐Costa AC, Carvalho A, et al. Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats. Physiol Rep. 2016;4:e12961. doi: 10.14814/PHY2.12961
  • Ahmed OM, Gabar MA, Ali TM. Impacts of the coexistence of diabetes and hypothyroidism on body weight gain, leptin and various metabolic aspects in albino rats. J Diabetes Complications. 2012;26:491–500. doi: 10.1016/J.JDIACOMP.2012.05.021
  • Eom YS, Wilson JR, Bernet VJ. Links between thyroid disorders and glucose homeostasis. Diabetes Metab J. 2022;46:239–256. doi: 10.4093/DMJ.2022.0013
  • Kawanami D, Matoba K, Utsunomiya K. Dyslipidemia in diabetic nephropathy. Ren Replace Ther. 2016;2:1–9. doi: 10.1186/S41100-016-0028-0
  • Kasiske BL, O’Donnell MP, Cleary MP, et al. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int. 1988;33:667–672. doi: 10.1038/KI.1988.51
  • Mahtal N, Lenoir O, Tharaux PL. Glomerular endothelial cell crosstalk with podocytes in diabetic kidney disease. Front Med. 2021; 8. doi: 10.3389/FMED.2021.659013
  • Yamauchi T, Ohnaka K, Takayanagi R, et al. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 1990;267:16–18. doi: 10.1016/0014-5793(90)80276-O